Antibodies against the serotype determinant epitopes of Moraxella catarrhalis lipopolysaccharides (LPS) were demonstrated in sera from rabbits immunised with whole bacterial cells. Purified LPS preparations from eight strains of M. catarrhalis were used as antigens in enzyme-linked immunosorbent assays (ELISA) and immunoblotting. The serotype specificity of the antibodies was shown by neutralisation with LPS and with purified polysaccharide obtained from LPS prepared from strains belonging to different serotypes. In immunoblots, antisera against the A and B LPS serotypes reacted only with LPS of its own type, confirming the presence of type-specific antibodies. A weak band was observed with type A LPS and antibody to type C, indicating cross-reactivity between the A and C serotypes. This cross-reaction can be explained on the basis of the known chemical structure of the LPS of the different serotypes. After heterologous absorption of sera, bands were obtained with homologous LPS antigen. These results suggest that the predominant antibody response in rabbits to LPS from M. catarrhalis is serotype-specific, unlike that previously observed in infected human patients.
Introduction
The lipopolysaccharide (LPS) of Moraxella catarrhalis lacks the 0-antigenic side chain characteristic of enteric pathogens [l-31, thus being similar in general structure to the LPS of Neisseria meningitidis, N. gonorrhoeae, Haemophilus influenzae and Bordetella pertussis [4-91. However, the LPS of these species vary in mol.wt, even within species, and variable banding patterns are often found after separation in SDS-PAGE [6-8, 10, 111. Furthermore, their complexity has been demonstrated by analysis of the antigenic variability found in different isolates of each species [6-8, 111.
The serological properties of the M. catarrhalis LPS indicate a less variable structure [12] . Three major antigenic types can be distinguished, accounting for 95% of all strains. Structural studies have shown that the carbohydrate parts of the LPS of the different Corresponding author: Dr M. Rahman serotypes consist of branched polysaccharides with a common inner core [2, 131 . Differences in terminal sugars appear to constitute the basis for the antigenic specificities of the three serotypes. A terminal a -~-GlcNAc-( 1 -2)-p-D-Glc was found to be specific for serotype A LPS [2, 3] , a terminal /?-D-Gal-( 1-4)-p-DGlc for serotype B (unpublished observation) and a terminal P-D-Gal-( 1 -4)-a-~-GlcNAc for serotype C [13] . The common inner core of the three serotypes contains a terminal a-D-Gal-( 1 -4)-/?-~-Gal-( 1 -4)-a-Glc epitope [2] . This epitope is also found in LPS from A? gonorrhoeae, N. rneningitidis and H. injluenzae [ 14, 1 51. Weak cross-reactions between M. catarrhalis and N. meningitidis have been described but not between M. catarrhalis and H. injluenzae [16, 17] . Cross-reactions between the different serotypes of M. catarrhalis, and in particular between serotypes A and C, have been described [12] .
Characterisation of the LPS of M. catarrhalis and its immunogenic epitopes would be useful for future studies of the possible protective capacity of anti-LPS antibodies. Antigenic similarities with other respiratory pathogens may be important for possible crossprotection. The present study investigated the presence
Preparation of antibodies and antigens
Rabbit antisera were produced against the eight test strains as described previously [18] . Purified LPS and lipid-free polysaccharide (PS) were prepared as reported previously [2] .
Absorption of antisera
All eight test strains and the LPS serotype reference strains were grown on sheep blood agar plates at 37°C overnight. The bacteria were then scraped off and washed three times in saline with centrifugation at 4000 g. Bacteria were resuspended in phosphatebuffered saline, pH7.5 (PBS). One ml of the bacterial suspension ( lo8 cfdml) was centrifuged at 5000 g and the pellet was resuspended in 1 ml of a 1 in 10 dilution of rabbit serum in PBS and incubated for 4 h at 37°C on a shaker. The mixture was then centrifuged at 5000 g at 4°C and the supernate was collected. This was called 'absorbed serum' and was stored at -20°C until use. For each antiserum, samples were absorbed with the homologous strain, the reference strains A, €3, C and the other seven test strains.
ELISA
Flat-bottom microtitration plates (Immunolon 11; Dynatech Laboratories, Virginia, USA) were coated with 100 pl of LPS of each test strain (10 pg/ml) in 0.05 M sodium carbonate coating buffer (pH 9.4) by incubation overnight at room temperature. The plates were washed four times with PBS containing Tween 20 0.5% (PBST) and each LPS was then incubated in duplicate for 2 h at 37°C with lOOp1 of two-fold serial dilutions of homologous unabsorbed serum (positive control), homologous absorbed serum (negative control), and antiserum absorbed by the reference strains of serotype A, B and C. After washing four times with PBST, plates were incubated for 1 h at 37°C with loop1 of horseradish peroxidase-conjugated sheep anti-rabbit immunoglobin (Binding Site), diluted 1 in 1000 in PBS. After washing, the reaction was developed by adding 100 p1 of substrate containing 3,5,3',5'-tetramethyl-benzidine (0.1 mg/ml) first dissolved in DMSO (10 mg/ml) and then added to a solution of H202 0.002% in 0.1 M sodium acetate (pH6.0). The reaction was stopped after 10 min by adding 50 pl of 2M H2S04 and the plates were read at 450 nm. The percentage inhibition of antiserum reactivity by absorption was calculated as described previously [ 191.
LPS and PS inhibition ELISA
LPS-coated plates were incubated for 2 h at 37°C with appropriate dilutions of homologous sera that had previously been incubated with two-fold serial dilutions of LPS or PS (15 pg/ml to 0.029 mg/ml) for 2 h at 37°C. The remainder of the assay was as described above. Inhibition was calculated as percentage of reduction in absorbance compared to a control without inhibitor and the concentration required for 50% inhibition was determined for each inhibitor.
SDS-PAGE and immunoblotting
Each LPS preparation was run in SDS-PAGE as described previously [2] and the gel was equilibrated in cold transfer buffer (25 m~ Tris-HC1 containing 192 m~ glycine, pH 8.3) for 30 min. Electrophoretic transfer of the sample to a nitrocellulose membrane was done at lOOV, 250mA for 1 h at 4°C. Nonspecific reactions were blocked by overnight treatment with skimmed milk 2% in PBS. The nitrocellulose membrane was then washed three times for 10 min each with skimmed milk 0.5% in Tris-buffered saline (TBS), pH7.5, sliced into strips and used for three different sets of experiments. Firstly, five strips were incubated with homologous unabsorbed antiserum, homologous absorbed antiserum, and antiserum absorbed by the reference strains of serotypes A, B and C. Secondly, eight strips were incubated separately with each of the eight test strain antisera and thirdly, eight strips were incubated with homologous antiserum absorbed by each of the eight test strains. All the above absorption experiments were incubated for 1 h at 37°C on a horizontal shaker with each antiserum diluted 1 in 100 in skimmed milk 0.5% in TBS.
The strips were then washed three times for 10 min each with skimmed milk 0.5% in TBS, and then incubated for 1 h at 37°C with affinity purified horseradish peroxidase-conjugated goat anti-rabbit IgG (BioRad Laboratories, CA, USA) diluted 1 in 1000 in TBS. They were washed again three times for 5 min each with skimmed milk 0.5% in TBS. Finally, the colour was developed by adding substrate containing ice-cold methanol 16%, 4-chloro-1 -naphthol 0.05%, H202 0.025% in TBS.
Results

Enzyme immunoassays
The antibody response against serotype determinant epitopes of M. catarrhalis LPS was analysed by ELISA with sera absorbed by bacterial cells of homologous and heterologous serotypes. The results obtained with antiserum against strain CCUG 3292 (type B) show no significant inhibition of antibody binding af€er heterologous absorption (with inner core similarity), indicating the predominance of antibodies against serotype determinant epitopes (Fig. 1) . Homologous absorption resulted in 98% inhibition. Similar results were obtained with all eight strains and their corresponding antisera.
To investigate a possible difference in reactivity of LPS immobilised on solid phase or free in solution and the possible role of antibodies to the common core of lipid A, LPS and PS were used as inhibitors in the ELISA. The concentrations of inhibitors required to give 50% inhibition of the homologous reaction between the solid phase LPS and antiserum are shown in Table 1 . When type A LPS was used as inhibitor for the reaction between type A LPS and its homologous antiserum, 50% inhibition was obtained at concentrations of 0.13-0.30 pglml, but no inhibition was recorded with type B or type C LPS (concentration > 15 pglml). The corresponding concentrations for 50% inhibition of type B antiserum by type B LPS were 1.8-2.1 pglml and for type C antiserum and type C LPS 0.13-1.8 pglml. Lipid-free polysaccharide derived from the LPS (PS) was used in similar inhibition experiments. The concentrations of PS required for 50% inhibition of homologous reactions were between 0.05 and 1.8 pglml.
Imm uno blotting
Immunoblotting was performed with LPS from the eight test strains with homologous antisera that were either unabsorbed, absorbed with the homologous strain or absorbed with the reference strains A, B or C. The immunoblot results for strain ATCC 25238 (Fig. 2) show that serum absorbed by the type A reference strain developed no band with ATCC 25238 LPS (lane 3) indicating the total absorption of anti-LPS antibodies. The presence of strong bands in lanes 4 and 5 shows the presence of antibodies to the serotype A determinant in serum after absorption with the reference strains B and C that have the same LPS core structure. Similar experiments with LPS preparations from all the other test strains and their homologous antisera confirmed the presence of serotype-specific antibodies (data not shown).
Immunoblotting with unabsorbed antisera was also performed with LPS from the eight test strains. When LPS from strain ATCC 25238 was immunoblotted with the eight antisera (Fig. 3) terminal disaccharide a-Gal-( 1 -4)-Gal of this trisaccharide is the receptor sequence in the uroepithelium for PapG, the adhesin expressed by pili of uropathogenic Escherichia coli [22] . It is also the receptor in the intestinal epithelium for the toxin secreted by Shigella shigae [22] . Another terminal disaccharide, /3-Gal-(l-4)-GlcNAc, which is specific for serotype C, is also expressed in H. injluenzae, h? gonorrhoeae and N. meningitidis, but coupled to a terminal sialic acid residue [23] . This disaccharide is also present in the human blood group antigen precursor, nLc4Cer [23] .
Human cells have been shown to possess surface lectins that bind to various polylactosaminylglycans with a terminal B-Gal-( 1-4)-GlcNAc [23] . LPS with a terminal N-acetyl-lactosamine structure may have a potential for acting as a ligand for lectins. Expression of these epitopes may be a defence strategy for the bacteria and a way to escape the immune defence or may be used during the stage of colonisation or early invasion [24] .
Phase variation of LPS antigens may occur at high frequency. Weiser et al. have shown that LPS epitope expression in vivo is different from that in vitro [25] . They have also shown that full length LPS is important for adhesion and invasion [24] . After invasion, bacteria with full length LPS are more susceptible to serum killing than those with short length LPS, and the organisms in which the terminal epitopes are switched off may be selected from among the population in response to the selective pressure of humoral immunity.
In sera from immunised rabbits, antibodies against the different LPS types were efficiently absorbed by whole bacteria of the corresponding type, showing that the LPS determinants were exposed on the surface of the cells used for absorption. In the demonstration of reactions between sera and the type A strain ATCC 25238, no bands were visible with the type B antisera, whereas a weak band was observed with type C antiserum. As shown by Vaneechoutte et al. [12] cross-reactions are common between type A and type C strains. We have shown recently that the 0-polysaccharide preparations from strain RS26 (type C) is a mixture of four saccharides [13] . A minor component contains the same disaccharide epitope that constitutes the serotype-specific determinant of serotype A LPS, explaining the cross-reactivity between types A and C. Another serotype C strain, RS10, contained only type C-specific LPS [13] . Direct LPS-ELISA confirmed the cross-reaction between type A strains and RS26 and the absence of cross-reaction with RS 10 (unpublished observations). The different structures of the LPS of the two serotype C strains could explain the differences in the concentrations required for 50% inhibition in the inhibition-ELISA by LPS from the two serotype C strains (Table 1) .
Type-specific neutralisation of antibodies by purified LPS corresponded well with the absorption by whole cells, indicating that no immunodominant determinants were exposed on the isolated LPS molecules in addition to those exposed on the surface of whole bacteria. Thus, there is no indication that the antigenic differences demonstrated may depend on determinants which are not available on the surface of the bacteria but are exposed in purified preparations of LPS. The study also demonstrated that the polysaccharide isolated after mild acid hydrolysis of the LPS was equally effective in neutralisation of type-specific antibodies.
The absence of heterologous reactions in immunoblots of LPS from type A and B strains (Fig. 4) indicates that type-specific antibodies predominate. As common antigenic determinants of the LPS have been shown to give rise to antibody responses in both man and experimental animals, cross-reactions could have been expected, especially as the rabbits used in this study were immunised for an extended period. In agreement with the results obtained by ELISA, a weak crossreaction was demonstrated in immunoblots of type A LPS with type C antiserum.
A previous study demonstrated an antibody response in human patients against LPS antigens of M. catarrhalis during respiratory tract infections with this organism [19] . However, the antibody response was not specific; titre rises were observed in many patients against all three LPS serotypes, rather than against the serotype isolated from the patient. This finding suggests that antibodies directed against the common epitopes of the M. catarrhalis LPS could constitute a significant part of the human antibody response during infection. The difference in antibody response between immunised rabbits and patients during infection with M. catarrhalis may be due to species-dependent differences in the immune response, to differences in antigen presentation, or to altered epitope expression by the bacteria after invasion of the host. The rabbits used for production of the antisera in the present study were immunised with killed bacteria, and, therefore, no phase variation could occur. As mentioned earlier, phase variation is a common phenomenon in H. influenzae [25] , and may occur in M. catarrhalis during infection. However, in the group of patients from whom M. catarrhalis was isolated, the titre rise was most pronounced against the A and B LPS serotypes, showing a preferential recognition of the most common serotypes. The human antibody response to M. catarrhalis LPS antigens during infection is thus complex, and the possible protective role of antibodies directed against different antigens has still to be evaluated. 
